Recently, minimally invasive Medical science co., LTD. (hereinafter referred to as "minimally invasive medicine") and the United States shares listed Medical devices company Lombard Medical announced that

Menarini - Silicon biosystems company said today that biological systems have yeung sum, Janssen and Johnson & Johnson subsidiary agreement, purchase yeung sum all the Cellsearch circulating tumor cells (CTC)

Since established in March 2014, Burning Rock Dx focused on for tumor patients and the risk of tumor population genetic testing services and medication guide. According to the different characteristics of solid tumor molecular classification,

On December 27, the largest ever acquisition of Abbott had obtained a breakthrough. The Federal Trade Commission The US Federal Trade Commission, FTC)

Thermo Fisher will invest £5 million in Premaitha as a secured loan facility, of which the company will receive £3 million initially and the remainder as milestone payments over the next two years.

Illumina recently announced that it has launched a new whole genome sequencing service with BioMerieux that the two companies have developed together.

Canature announced in the morning of Dec. 21, Origincell Technology Group, its holding subsidiary signed a strategic cooperative agreement with NextCODE on Dec. 17

? A cooperative agreement has been announced by Illumina and Novogene on 15th of this month to jointly develop the Next Generation of Sequencing platform

Google Ventures is going to start off 2016 with $2.4 billion under management. This year, life sciences and health remained the most active area of investment

The note shows, Marr Bio’s revenues from January to June in 2015 is ￥8.77 million, and net profit is ￥1.67 million.

Aspire Capital is a growth equity firm focused on making direct investments into public companies across various industries.

BGI recently announced that it has cooperated again with PacBio, which is the leader of the real-time single-molecule sequencing technology (SMRT), to purchase Asia’s first Sequel sequencing system.

The National Institutes of Health announced that it aims to award $2 million in grant funding in fiscal year 2017 for research around new biomarkers to diagnose active pulmonary tuberculosis (TB)

The National Institutes of Health has announced that it will allocate further funding to support the refinement of molecular cancer diagnostics

Recently, Shenzhen iCubio Biomedical Technology Co., Ltd. was approved to list on the new OTC market and public transfer.